Abstract: . . .  blockers, angiotensin II receptor inhibitors and angiotensin-converting enzyme inhibitors have been shown to reduce intimal hyperplasia in clinical TxCAD (Schroeder et al., 1993; Mehra et al., 1995; Furukawa et al., 1996). Page 25 25 Table 3. Clinical and experimental interventions preventing TxCAD Molecules Observations References Experimental studies in Italics Immunosuppressives Cyclosporine A Reduces TxCAD Low dose is a risk for TxCAD Koskinen et al., 1995 Gamba et al., 1997 . . .
. . .  electrophoresed through 2% agarose. The gel was dried (LKB 2003 Slab Gel Dryer, LKB, Bromma, Sweden), exposed to imaging plate (Fuji Photo Film Co., Tokyo, Japan) and the gels were quantified using a Fuji BAS1500 phosphoimager. The mean values of three determinations were used for final analysis and the normalized mRNA levels were Page 31 31 derived by dividing the mean of the mRNA of the gene of interest by the mean of GAPDH mRNA for each tissue sample. To identify the optimal PCR conditions for accurate measurement of each gene transcript, . . .
. . .  et al., 1997 Ganciclovir+CMV hyperimmune globulin Intensity and prevalence of TxCAD was lower after 3 years in Ganciclovir+CMVIG treated group than group treated by Ganciclovir alone. Valantine et al., 2001 HMG-CoA reductase inhibitors Increase survival and decrease incidence of TxCAD Kobashigawa et al., 1995; Wenke et al., 2003 Page 26 26 AIMS The purpose of this study was to investigate crosstalk between PDGF and proinflammatory cytokines (TNF- a , IL-1 . . .
. . .  while almost all patients have histological evidence of the disease already one year after cardiac transplantation (Johnson et al., 1991). 3.2. Clinical presentation TxCAD is usually clinically silent due to denervation of the transplanted heart, until it has progressed to end-stage disease (Gao et al., 1987). The usual manifestations are congestive heart failure, life-threatening arrhythmias, or a sudden death. The outcome is because of the ischemic nature of the disease; the whole arterial network is affected by intimal thickening and luminal narrowing . . .
. . .  pumping after circulation into the graft was established. Aorta. An approximately 3-cm long segment of the descending thoracic aorta was removed, thoroughly perfused with PBS, and used as a transplant (Mennander et al., 1991). A segment of the recipients abdominal aorta between renal vessels and bifurcation was clamped, removed and replaced by the graft using end-to-end anastomosis. Total ischemic time was 3510 min, during which time the graft was kept in ice-cold PBS for 15 min and for the rest of the time the graft was cooled by ice cold PBS gauze. 2. . . .
--3000,5,300,3382,64606